Science


Posts filtered by tags: Biotech[x]


 

Cell and gene therapy startup ElevateBio raises $170M

While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant money committed. Cambridge-based ElevateBio, for instance, revealed a $170 million Series B funding on Monday, with participation from new investors The Invus Group, Surveyor Capital, EDBI, and Vertex Ventures, along with existing investors F2 Ventures, MPM Capital, EcoR1 Capital, Redmile Group and Sams...
Tags: Health, Startups, TC, Science, Biology, Drugs, Massachusetts, Tech, Cambridge, Manufacturing, Biotech, Stem Cell, Pharma, Biotechnology, Life Sciences, Baylor College of Medicine


Cell and gene therapy startup ElevateBio raises $170 million

While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant money committed. Cambridge-based ElevateBio, for instance, revealed a $170 million Series B funding on Monday, with participation from new investors The Invus Group, Surveyor Capital, EDBI, and Vertex Ventures, along with existing investors F2 Ventures, MPM Capital, EcoR1 Capital, Redmile Group and Sams...
Tags: Health, Startups, TC, Science, Biology, Drugs, Massachusetts, Tech, Cambridge, Manufacturing, Biotech, Stem Cell, Pharma, Biotechnology, Life Sciences, Baylor College of Medicine


A new FDA-authorized COVID-19 test doesn’t need a lab and can produce results in just 5 minutes

There’s a new COVID-19 test from healthcare technology maker Abbott that looks to be the fastest yet in terms of producing results, and that can do so on the spot right at point-of-care, without requiring a round trip to a lab. This test for the novel coronavirus causing the current global pandemic has received emergency clearance for use by the U.S. Food and Drug Administration, and will begin production next week, with output of 50,000 per day possible starting next week. The new Abbott ID ...
Tags: Health, TC, Science, Medicine, Tech, United States, Healthcare, Food And Drug Administration, Fda, Biotech, Viruses, Infection, Abbott, Veterinary Medicine, U S Food and Drug Administration, Coronavirus


Frontiers launches a portal to help connect coronavirus and COVID-19 research with funding

Open science platform and publisher Frontiers wants to make sure that efforts by researchers to pursue science-based solutions to the global coronavirus pandemic, and learn more about the virus and the COVID-19 disease it causes, find the funding they need. They launched a new portal to do just that, which is updated daily, and lists open funding calls, including the grant type, deadline, organization behind it, and specific area it supports. Sources include governments, non-profits, and commerc...
Tags: Health, TC, Science, Tech, Research, Biotech, Viruses, Frontiers, Coronavirus, COVID-19, COVID


How one company is fast-tracking development of potential plasma-based treatments for the coronavirus

Medical biotech company Emergent BioSolutions is one of the many health industry players turning its efforts towards addressing the current global coronavirus pandemic. Their work includes a two-pronged effort to pursue plasma-based treatments that could help lessen the impact of COVID-19 on health care systems, with a fast-tracked development timeline that could see human clinical trials start as soon as this summer. The company is simultaneously working on two different therapeutic approaches,...
Tags: Health, TC, Science, Medicine, Tech, Food And Drug Administration, Fda, Manufacturing, Biotech, Infection, Head, Drug Development, Emergent, Saward, Coronavirus, COVID-19


UK researchers develop new low-cost, rapid COVID-19 test that could even be used at home

A new type of test developed by UK researchers from the Brunel University London, Lancaster University and the University of Surrey can provide COVID-19 detection in as little as 30 minutes, using hand-held hardware that costs as little as £100 (around $120 USD) with individual swab sample kits that cost around $5 per person. The test is based on existing technology that has been used in the Philippines for testing viral spread in chickens, but it’s been adapted by researchers for use with COVID...
Tags: Health, TC, UK, Science, Medicine, China, Tech, Eu, European Union, Smartphone, Philippines, United Kingdom, Fda, Biotech, Software Testing, University of Surrey


YC startup Felix wants to replace antibiotics with programmable viruses

Right now the world is at war. But this is no ordinary war. It’s a fight with an organism so small we can only detect it through use of a microscope — and if we don’t stop it, it could kill millions of us in the next several decades. No, I’m not talking about COVID-19, though that organism is the one on everyone’s mind right now. I’m talking about antibiotic-resistant bacteria. You see, more than 700,000 people died globally from bacterial infections last year — 35,000 of them in the U.S. If we ...
Tags: Health, Startups, TC, Y Combinator, Science, Medicine, Articles, Tech, United States, United Nations, Disease, Jurassic Park, Fda, Biotech, Antibiotic Resistance, TechCrunch


This cancer treatment gives patients night-vision, and we finally know why

In the early 2000s, it was reported that some cancer patients being treated with chlorin e6 were experiencing enhanced night vision.Using a molecular simulation, researchers discovered that a chlorin e6 injection under infrared light activates vision by changing retinal in the same way that visible light does. Researchers hope that this chemical reaction could one day be harnessed to help treat certain types of blindness and sensitivity to light. In the early 2000s, it was reported that a...
Tags: Science, Biology, France, Cancer, Medical Research, Innovation, Algorithm, Biotech, Biomechanics, CNRS, Molecular Biology, University of Lorraine, Human body, Antonio Monari, Monari


You’ve heard of CRISPR, now meet its newer, savvier cousin CRISPR Prime

CRISPR, the revolutionary ability to snip out and alter genes with scissor-like precision, has exploded in popularity over the last few years and is generally seen as the standalone wizard of modern gene-editing. However, it’s not a perfect system, sometimes cutting at the wrong place, not working as intended and leaving scientists scratching their heads. Well, now there’s a new, more exacting upgrade to CRISPR called Prime, with the ability to, in theory, snip out more than 90% of all genetic d...
Tags: TC, Science, Biology, Breast Cancer, Cancer, Hiv, Tech, Genetics, Healthcare, Disease, Biotech, Malaria, Genetic Engineering, Crispr, Biotechnology, Emerging-technologies


A startup just launched red wine to the International Space Station to age for 12 months

Space-based businesses don’t all have to be about communications or Earth observation – European startup Space Cargo Unlimited, for instance, is focused on what operating in a microgravity environment can unlock for research and manufacturing. Accordingly, the company just launched an unusual payload to the International Space Station (ISS) – twelve bottles of wine. The wine is not leisure-time supplies for the astronauts on board the ISS; instead, it’s part of an experiment that will study how ...
Tags: Startups, TC, Space, Science, Tech, Research, Earth, International Space Station, Manufacturing, Biotech, Iss, Radiation, Spaceflight, Aerospace, Spacecraft, Northrop Grumman


In the Accelerator over the Sea

In our oceans the scale of disasters is measured in millions, billions, and trillions, while solutions amount to single digits: individuals or institutions working to impact a chosen issue with approaches often both brilliant and quixotic. Putting such individuals in close contact with both whales and billionaires is the strange alchemy being attempted by the Sustainable Ocean Alliance’s Accelerator at Sea. I and a few other reporters were invited to observe said program, a five-day excursion in...
Tags: Google, Startups, TC, Gadgets, Science, Hardware, Funding, Tech, Artificial Intelligence, Conservation, Alaska, Silicon Valley, Biotech, Robotics, GreenTech, Bahamas


Groupon co-founder Eric Lefkofsky just raised another $200 million for his newest company, Tempus

When serial entrepreneur Eric Lefkofsky grows a company, he puts the pedal to the metal. When in 2011 his last company, the Chicago-based coupons site Groupon, raised $950 million from investors, it was the largest amount raised by a startup, ever. It was just over three years old at the time, and it went public later that same year. Lefkofsky seems to be stealing a page from the same playbook for his newest company, Tempus. The Chicago-based genomic testing and data analysis company was foun...
Tags: Startups, TC, Science, Groupon, Tech, Biotech, Revolution Growth, Baillie Gifford, Eric Lefkofsky, Drug Development, Tempus, Recent Funding


Groupon cofounder Eric Lefkofsky just raised another $200 million for his newest company, Tempus

When serial entrepreneur Eric Lefkofsky grows a company, he puts the pedal to the metal. When in 2011 his last company, the Chicago-based coupons site Groupon, raised $950 million from investors, it was the largest amount raised by a start-up, ever. It was just over three years old at the time, and it went public later that same year. Lefkofsky seems to be stealing a page from the same playbook for his newest company Tempus. The Chicago-based genomic testing and data analysis company was foun...
Tags: Startups, TC, Science, Groupon, Tech, Biotech, Revolution Growth, Baillie Gifford, Eric Lefkofsky, Drug Development, Recent Funding


Scientists pull speech directly from the brain

In a feat that could eventually unlock the possibility of speech for people with severe medical conditions, scientists have successfully recreated the speech of healthy subjects by tapping directly into their brains. The technology is a long, long way from practical application but the science is real and the promise is there. Edward Chang, neurosurgeon at UC San Francisco and co-author of the paper published today in Nature, explained the impact of the team’s work in a press release: “For the f...
Tags: Health, TC, Science, Tech, Artificial Intelligence, Biotech, Brain-computer Interface, UCSF, UC San Francisco, Broca, Wernicke, Edward Chang, Synthetic Speech, Gopala Anumanchipalli, Anumanchipalli, Josh Chartier


GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”

San Antonio—GenCure, a subsidiary of life sciences nonprofit BioBridge Global, expects to open a biomanufacturing laboratory this year at a new “innovation center” that’s being developed by VelocityTX in San Antonio.GenCure is a regenerative medicine-focused organization that accepts and stores bone marrow and umbilical cord blood, which it uses to produce adult stem cells for research. BioBridge plans to lease 21,000 square feet of space for GenCure at the new four-acre VelocityTX complex, whi...
Tags: Energy, Startups, Accelerator, Texas, Science, Technology, Funding, Entrepreneur, Trends, Startup, Tech, Tax, Cybersecurity, Emerging Technology, Incubator, Innovation


VelocityTX Lands City Grant for “Innovation Center” Redevelopment

San Antonio — VelocityTX is getting a $750,000 grant and another tax incentive from the City of San Antonio for its redevelopment of a large industrial space that VelocityTX plans to turn into a three-building “innovation center” for tech, life sciences, and other businesses.VelocityTX, which is the innovation arm of nonprofit business development organization Texas Research and Technology Foundation, is rebuilding the complex in four phases over the course of 10 years, and says it plans to spe...
Tags: Energy, Startups, Accelerator, Texas, Science, Technology, Funding, Entrepreneur, Trends, Startup, Tech, Tax, Cybersecurity, Emerging Technology, Incubator, Innovation


Work on world’s first CRISPR gene-edited babies declared illegal by China

Chinese authorities have declared the work of He Jiankui, who shocked the scientific community by claiming he successfully created the world’s first gene-edited babies, an illegal decision in pursuit of “personal fame and gain.” Investigators have completed preliminary steps in a probe that began in November following He’s claims and say they will “seriously” punish the researcher for violations of the law, China’s official news agency Xinhua reported on Monday. He, who taught at Shenzhen’s Sout...
Tags: Asia, Science, Biology, China, Tech, Genetics, United States, Biotech, Crispr, Shenzhen, Emerging-technologies, Xinhua, Southern University of Science and Technology, He Jiankui


Bumblebees bearing high-tech backpacks act as a living data collection platform

There’s lots of research going into tiny drones, but one of the many hard parts is keeping them in the air for any real amount of time. Why not hitch a ride on something that already flies all day? That’s the idea behind this project that equips bumblebees with sensor-filled backpacks that charge wirelessly and collect data on the fields they visit. A hive full of these cyber-bees could help monitor the health of a field by checking temperature and humidity, as well as watching for signs of rot ...
Tags: TC, Gadgets, Wearables, Internet Of Things, Science, Hardware, Tech, Bees, Iot, Biotech, University of Washington, Sawyer Fuller, Shyam Gollakotta, Gollakotta


Bumble bees bearing high-tech backpacks act as a living data collection platform

There’s lots of research going into tiny drones, but one of the many hard parts is keeping them in the air for any real amount of time. Why not hitch a ride on something that already flies all day? That’s the idea behind this project that equips bumble bees with sensor-filled backpacks that charge wirelessly and collect data on the fields they visit. A hive full of these cyber-bees could help monitor the health of a field by checking temperature and humidity, as well as watching for signs of rot...
Tags: Travel, TC, Gadgets, Wearables, Internet Of Things, Science, Hardware, Bees, Iot, Biotech, University of Washington, Sawyer Fuller, Shyam Gollakotta, Gollakotta


Watch biotech startups pitch at IndieBio’s demo day today

IndieBio, the biotech startup accelerator that’s produced heaps of notable companies (including several that have graced the Startup Battlefield), is holding its twice-annual demo day today at 3PM Pacific Time. An even dozen young companies will be pitching their work, from AI-informed research to artificial meat, and you can watch them present live right here. The IndieBio program is a four-month one that takes companies at the seed stage, often researchers straight out of graduate programs or ...
Tags: Travel, Startups, Accelerator, Science, Hardware, Silicon Valley, Biotech, Bio, Indiebio, SOSV, Startup Battlefield, Chronus, Oralta, Quartolio


CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable

Marijuana may still be on shaky legal ground, but the therapeutic benefits of the psychoactive molecules — cannabinoids — inside the plant are solidly established. Unfortunately, cultivation of that plant is resource-intensive and yields only tiny amounts of some useful medicines. CB Therapeutics, a new biotech company launching today at the Disrupt SF Startup Battlefield, aims to change the game with cannabinoids produced cleanly and cheaply in the lab — out of sugar. Co-founder and CEO Sher Al...
Tags: TC, Science, Events, Tech, Biotech, Bio, GreenTech, Battlefield, Disrupt, Genentech, CB Therapeutics, Disrupt Sf 2018, Disrupt SF Startup Battlefield, Sher Ali Butt, Steep Hill CBD, Jacob Vogan


George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla

Nebula Genomics, the startup that wants to put your whole genome on the blockchain, has announced the raise of $4.3 million in Series A from Khosla Ventures and other leading tech VC’s such as Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures and Heartbeat Labs. Nebula has also has forged a partnership with genome sequencing company Veritas Genetics. Veritas was one of the fir...
Tags: Health, Startups, TC, Science, Biology, Privacy, Big Data, Funding, Tech, Ceo, Smartphone, Mit, Genetics, Genomics, Biotech, Bio


RDMD attacks rare diseases with data mined from health records

You wouldn’t expect a medical app to get its start as a Snapchat competitor. Neither did video chat startup TapTalk’s founder Onno Faber. But four years ago he was diagnosed with a rare disease called  Neurofibromatosis Type 2 that caused tumors leading Onno to lose hearing in one ear. He’s amongst the one in ten people with an uncommon health condition suffering from the lack of data designed to invent treatments for their ails. And he’s now the co-founder of RDMD. Emerging from stealth toda...
Tags: Travel, Health, Fundings & Exits, Startups, TC, Apps, Science, Funding, Healthcare, Disease, Fda, Biotech, Bio, Nancy, Shasta, 23andMe


Cytera Cellworks aims to bring cell culture automation to your dinner plate

Cytera Cellworks hopes to revolutionize the so-called ‘clean meat’ industry through the automation of cell cultures — and that could mean one day, if all goes to plan, the company’s products could be in every grocery store in America. Cytera is a ways off from that happening, though. Founded in 2017 by two college students in the U.K., Ignacio Willats and Ali Afshar, Cytera uses robotic automation to configure cell cultures used in things like growing turkey meat from a petri dish or testing ste...
Tags: Startups, TC, Y Combinator, Science, Tech, Biotech, Hampton Creek, Memphis Meats, Afshar, Imperial College of London, Cytera Cellworks, America Cytera, Ignacio Willats, Ali Afshar Cytera, Willats


Mammoth Biosciences raises $23 million for its CRISPR-based disease detection engine

Mammoth Biosciences, the biotech company that grew out of a close relationship with CRISPR legend Jennifer Doudna, has raised $23 million in a sturdy Series A. Mammoth previously raised $120,000 from NFX and the company continued quietly picking up funding as it built toward its exit from stealth mode in April 2018. Its current round was led by Mayfield with participation from NFX and 8VC. Mammoth also has some high profile interest from individual investors. Apple’s Tim Cook and Jeff Huber, ...
Tags: Apple, Health, TC, Wtf, Science, Stanford, Funding, Tech, Tim Cook, Biotech, UC Berkeley, Crispr, Cto, Martin, Jennifer Doudna, Mayfield


Genmed delivers cost competitive vendor neutral managed services for two NHS Trusts in Wirral and West Cheshire

July 19, 2018 – Genmed announces today that it is delivering a variety of vendor neutral managed services for the Countess of Chester NHS Foundation Trust, Wirral University Teaching Hospital NHS Foundation Trust and a shared medical microbiology service run by Read more…
Tags: Science, Seo, It, Healthcare, Biotech, NHS Trusts, News Trends, West Cheshire


UK Ethics Council Says It’s ‘Morally Permissible’ to Create Genetically Modified Babies

The UK’s Nuffield Council on Bioethics says it’s acceptable to genetically engineer human embryos, so long as the interventions aren’t harmful to the future child or society as a whole. The council is taking a surprisingly progressive position on the matter, but we’re still a long way off from the birth of the…Read more...
Tags: UK, Science, Ethics, Biotech, Crispr, Biotechnology, Bioethics, Gene Editing, Designer Babies, Nuffield Council on Bioethics, Human Trait Selection, Create Genetically Modified Babies


CRISPR DNA editing may cause serious genetic damage, researchers warn

CRISPR-Cas9, the gene-editing tool that is currently the darling of biotech and many other fields, may not be quite as miraculous as early tests suggested. A new study finds that what scientists thought of as a scalpel may be more like a felling axe, causing damage hundreds of times what was previously observed. Before anyone panics and checks out the window for mutated monstrosities, it should be said right away that this isn’t a nightmare scenario by any means: the tool can still be used in ma...
Tags: Health, Science, Tech, Biotech, Genes, Bio, Crispr, Bradley, Crispr Cas9, Allan Bradley, Wellcome Sanger Institute, Michael Kosicki Kärt Tomberg


Implantable 3D-printed organs could be coming sooner than you think

At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big step on the path toward developing viable 3D-printed organs for humans. The company, which was founded in 2016 by research scientists Melanie Matheu and Noelle Mullin, staked its future (and a small $3 million investment) on a new technology to manufacture capillaries, the one-cell-thick blood vessels th...
Tags: Health, TC, Science, Biology, Medicine, San Francisco, Tech, Engineer, Diabetes, United States, 3d Printing, Biotech, Printing, Advisor, Biotechnology, Organ


Disgraced Theranos CEO Elizabeth Holmes Is Allegedly Looking to Start Another Company

Elizabeth Holmes lost everything—and nearly $900 million of other people’s money—when her bunk blood-testing startup Theranos went into full meltdown, resulting in the layoff of nearly all staff and civil charges of “massive” fraud for Holmes and former company president Ramesh “Sunny” Balwani.Read more...
Tags: Startups, Science, Technology, Medicine, Silicon Valley, Biotech, Biotechnology, Theranos, Elizabeth Holmes, Holmes, Ramesh, Start Another Company



Filters
show more filters
February - 2020
MoTuWeThFrSaSu
     12
3456789
10111213141516
17181920212223
242526272829 
March - 2020
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
3031     
March - 2020
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
3031